diazoxide (ATH-012)
/ Neurotec Pharma, Advancell
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
June 13, 2025
A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
(clinicaltrials.gov)
- P2 | N=160 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Not yet recruiting ➔ Recruiting
Enrollment open • Melanoma • Oncology • Solid Tumor
May 07, 2025
A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
(clinicaltrials.gov)
- P2 | N=160 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
New P2 trial • Melanoma • Oncology • Solid Tumor
November 09, 2023
'I am tired, sad and kind': self-evaluation and symptoms of depression in adolescents.
(PubMed, Child Adolesc Psychiatry Ment Health)
- "As predicted by the cognitive model of depression, our findings suggest that adolescents with elevated symptoms of depression generated more negative self-evaluation words than healthy adolescents; however they also generated prosocial positive self-evaluation words at the same rate as non-depressed adolescents. These novel data therefore identify an 'island' of resilience that could be targeted and amplified by psychological treatments for adolescent depression, and thus provide an additional technique of change."
Journal • CNS Disorders • Depression • Mood Disorders • Psychiatry
May 03, 2023
"बद्रीनाथ आरती के रचयिता के पैतृक घर पहुंचे पूर्व मुख्यमंत्री त्रिवेन्द्र... https://t.co/6cNI5DbNKx via @YouTube @pushkardhami @TIRATHSRAWAT @MahantDilipRwt @RajkumarPorimla @REAL___HINDUVT @HinduMakhanSing @bkonety @Badrinath2012 @HinduSanatanDh3 @hindusanatan86 @DarmoraSanjay"
(@voice_mountains)
1 to 4
Of
4
Go to page
1